Transfusion

New Study Shows Mixed Reality Technology for Blood Donation from Abbott and Blood Centers of America Helps Ease Stress, Encourages People to Donate Again

Retrieved on: 
Thursday, February 1, 2024
Johns Hopkins University, Anxiety, Quad Cities, Needle, Research, Fear, Transfusion, Flower, Environment, Music, Stanford University, University School, Blood, BCA, Plasma, Seed, Medical device

Abbott, the global leader in screening blood and plasma, partnered with Blood Centers of America, the largest blood supplier network in the U.S., to launch a mixed reality experience for blood donors in June 2023.

Key Points: 
  • Abbott, the global leader in screening blood and plasma, partnered with Blood Centers of America, the largest blood supplier network in the U.S., to launch a mixed reality experience for blood donors in June 2023.
  • The Abbott and BCA mixed reality innovation is an immersive digital experience designed to improve the blood donation process, attract new donors and motivate a younger generation to give blood.
  • Donors wear lightweight mixed reality headsets to visit a digital world while remaining fully aware of their real-world surroundings.
  • The mixed reality experience allows blood donation professionals to safely conduct the donation and interact with donors at every step of the process.

Study Confirms that Frequency of Source Plasma Donation as Regulated by U.S. FDA Does Not Impair Donor Health and Well-Being

Retrieved on: 
Friday, August 25, 2023
Plasmapheresis, Blood, Research, U.S. FDA, Plasma, Transfusion, Quality of life (healthcare), PPTA, Cough, Health, Safety, Medical device

The results of this peer-reviewed study indicate that, based on donor self-reporting, compensated Source Plasma donations at U.S. FDA-permitted frequencies and volumes are consistent with maintaining donor health and safety.

Key Points: 
  • The results of this peer-reviewed study indicate that, based on donor self-reporting, compensated Source Plasma donations at U.S. FDA-permitted frequencies and volumes are consistent with maintaining donor health and safety.
  • This PPTA-sponsored research was designed to assess the impact of U.S. donation frequency on donor self-reported health and well-being.
  • Additionally, data show that when compared with the general population, Source Plasma donors have comparable or better self-reported health.
  • This research adds to the body of scientific evidence that shows repeat plasma donation is safe and does not adversely impact donor health," said Anita Brikman, PPTA President and CEO.

Study Confirms that Frequency of Source Plasma Donation as Regulated by U.S. FDA Does Not Impair Donor Health and Well-Being

Retrieved on: 
Friday, August 25, 2023
Plasmapheresis, Blood, Research, U.S. FDA, Plasma, Transfusion, Quality of life (healthcare), PPTA, Cough, Health, Safety, Medical device

The results of this peer-reviewed study indicate that, based on donor self-reporting, compensated Source Plasma donations at U.S. FDA-permitted frequencies and volumes are consistent with maintaining donor health and safety.

Key Points: 
  • The results of this peer-reviewed study indicate that, based on donor self-reporting, compensated Source Plasma donations at U.S. FDA-permitted frequencies and volumes are consistent with maintaining donor health and safety.
  • This PPTA-sponsored research was designed to assess the impact of U.S. donation frequency on donor self-reported health and well-being.
  • Additionally, data show that when compared with the general population, Source Plasma donors have comparable or better self-reported health.
  • This research adds to the body of scientific evidence that shows repeat plasma donation is safe and does not adversely impact donor health," said Anita Brikman, PPTA President and CEO.

Celebrated artivist Nikkolas Smith illustrates reality of patients living with sickle cell disease

Retrieved on: 
Monday, June 19, 2023
American Red Cross, Bell, Friends, Stroke, End organ damage, HOW, Black, Pain, Transfusion, Patient, CELL, Blood, Anemia, International Red Cross and Red Crescent Movement, Sickle cell disease, Red, Health, African Americans, Disease, Pharmaceutical industry, Vaccine, Medical device

WASHINGTON, June 19, 2023 /PRNewswire/ -- Celebrated artist Nikkolas Smith revealed exclusive artwork today illustrating the important role blood donations play for people living with sickle cell disease, the most common — yet often invisible to the public eye — genetic blood disorder in the U.S., which predominantly affects those in the Black community.

Key Points: 
  • One in three African Americans are a match for people with sickle cell disease.
  • Smith sat down with four sickle cell warriors of various ages — Tiereny Bell, Dr. Rubin Beaufort, Dreylan Holmes and Erica Hunter — to capture and represent their lived experiences in "Transfusion."
  • An estimated 100,000 people across the U.S. — the majority of whom are of African descent — have sickle cell disease and may require regular blood transfusions to help manage their disease.
  • "I was so moved to learn how [sickle cell warriors'] health greatly improves after every generous blood donation and transfusion," Smith reflected.

EdiGene to Present Preliminary Safety and Efficacy Results of an Investigator Initiated Trial for ET-01, its Investigational Gene Editing Hematopoietic Stem Cell Therapy, at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition

Retrieved on: 
Thursday, November 3, 2022
Health, Stem Cells, Genetics, Research, Science, Pharmaceutical, Biotechnology, Patient, Stem cell, RNA, Chinese Academy of Sciences, Cas9, Research, CD34, Society, Institute, Peking Union Medical College, NMPA, TDT, IND, Knowledge, ASH, Regenerative medicine, CEO, National Medical Products Administration, Fetal hemoglobin, Medicine, Chinese Academy of Medical Sciences COVID-19 vaccine, Gene editing, Exposition, CRISPR, Transfusion, BCL11A, Hope, Pharmaceutical industry, Medical device, Vaccine, Hematology

It is reported to be approximately 15,000 to 30,000 patients with -Thalassemia Major (-TM) in China.

Key Points: 
  • It is reported to be approximately 15,000 to 30,000 patients with -Thalassemia Major (-TM) in China.
  • A recent cross-sectional survey initiated by the Institute of Hematology & Blood Diseases Hospital found that only 7% of the samplings are expected to live beyond age 18.
  • The safety profile of ET-01 was consistent with that of autologous hematopoietic stem cell transplantation and myeloablative conditioning.
  • ET-01 is currently in a multi-center Phase I clinical trial in China, with subjects enrollment completed earlier this year.

Secure Transfusion Solutions Announces Company Name Change and Opening of its Third Trusting Heart Blood Center in Beaverton, Oregon

Retrieved on: 
Wednesday, July 20, 2022
Time, GLOBE, OR, Trust, Industry, Bleeding, Hospital, STS, CEO, Solution, Collection, Transfusion, Safety, Cancer, Quality of life, World Blood Donor Day, Patient, Blood, THBC, Hope, Suite, Growth, Blood product, Medical device

The transition of the companys name comes at a time of rapid expansion and continued growth within the blood transfusion industry.

Key Points: 
  • The transition of the companys name comes at a time of rapid expansion and continued growth within the blood transfusion industry.
  • The opening of the THBC Beaverton collection center marks a major milestone in our mission to permanently increase patient and hospital access to secure and sustainable platelet supplies across the nation, said Vijai Mohan, Founder and CEO of Secure Transfusion Solutions.
  • Secure Transfusion Solutions (STS) is a life sciences company pioneering innovative methods to overcome the nations growing blood and platelet shortage.
  • Its purpose is to restore hope, build trust and improve quality of life by increasing patient access to readily available and safe transfusion solutions.

Ready-to-Drink (RTD) Cocktail Company, Caddy Clubhouse Cocktails, Announces Expanded Distribution Into Multiple New Markets

Retrieved on: 
Tuesday, June 14, 2022
Half & Half, Tea, Transfusion, Cocktail, One half, Social media, Golf, Instagram, Liquor, Facebook

RALEIGH, N.C., June 14, 2022 /PRNewswire/ -- Caddy Clubhouse Cocktails, a new to market golf inspired ready-to-drink cocktail line, announced today expanded distribution into multiple new markets across the country.

Key Points: 
  • RALEIGH, N.C., June 14, 2022 /PRNewswire/ -- Caddy Clubhouse Cocktails, a new to market golf inspired ready-to-drink cocktail line, announced today expanded distribution into multiple new markets across the country.
  • Caddy Cocktails will be featured via a soon-to-launch video series entitled: Caddy Confidential Series, highlighting real golf caddies from around the world.
  • Crafted with vodka, these ready-to-drink vodka cocktails include the iconic golf cocktail, the Transfusion and the classic Half & Half.
  • To learn more about our services and more, please visit https://nextcenturyspirits.com/ and or check us out on Instagram or Facebook .

KORU Medical Systems Appoints Brian Case As Chief Technology Officer

Retrieved on: 
Monday, April 18, 2022
Health, Medical Supplies, Medical Devices, Linda, Flo, Horizon Fuel Cell Technologies, CEO, Certified Project Management Professional, FREEDOM, NASDAQ, KORU, Research, R, Patient, KRMD, Champaign County, Illinois, Technology, Med Systems Software, Company, Research and development, Fresenius (company), Transfusion, Mechanics, Acquisition, Quality of life, University, Biomedical Advanced Research and Development Authority, Rose–Hulman Institute of Technology, Cook Group, Medical device, Management, Engineering, Science

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced the appointment of Brian Case, a veteran medical technology R&D leader with over 20 years of experience, as the Companys new Chief Technology Officer.

Key Points: 
  • Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced the appointment of Brian Case, a veteran medical technology R&D leader with over 20 years of experience, as the Companys new Chief Technology Officer.
  • Brian joins the KORU Medical Systems team with over 20 years of research and development experience.
  • Prior to Fresenius Kabi, Mr. Case spent six years at Cook Medical, a medical device company, as R&D Program Manager, Advanced Research.
  • Im honored to be joining KORU at such a transformational stage in the companys journey, said Brian Case.

Next Century Spirits Debuts Caddy Clubhouse Cocktails: A Brand New Ready-to-Drink (RTD) Cocktail in Partnership with Golf Legend Greg Norman

Retrieved on: 
Monday, March 7, 2022
Link, Great white shark, The Century Club of San Diego, Chief executive officer, Instagram, Growth, Tea, Golf, One half, CEO, Half & Half, RTD, Partnership, Transfusion, The War of the Worlds: Next Century, Liquor, Sports equipment, Facebook

RALEIGH, N.C., March 7, 2022 /PRNewswire/ -- Next Century Spirits, a leading full-service distilled spirits company, today announced the debut of their first-ever ready-to-drink (RTD) canned cocktail offering with the launch of Caddy Clubhouse Cocktails in partnership with internationally renowned golf legend, Greg Norman.

Key Points: 
  • RALEIGH, N.C., March 7, 2022 /PRNewswire/ -- Next Century Spirits, a leading full-service distilled spirits company, today announced the debut of their first-ever ready-to-drink (RTD) canned cocktail offering with the launch of Caddy Clubhouse Cocktails in partnership with internationally renowned golf legend, Greg Norman.
  • "I can't think of a more fitting partner than Next Century for this incredibly exciting project," states Norman.
  • "Our goal is to make Caddy Clubhouse Cocktails to become 'The Official Drink of the Links' for golfers across the country."
  • Caddy Clubhouse Cocktails joins Creek Water Whiskey and Bear Fight American Single Malt in Next Century Spirits owned brand portfolio.

Insights on the Blood Transfusion Diagnostics Global Market to 2027 - Rising Demand for Donor Screening is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, January 17, 2022
Medical Devices, Health, CAGR, Patient, Application, Viral Research and Diagnostic Laboratories, Blood transfusion, Hepatitis B, Transfusion transmitted infection, HIV, Transfusion, Hepatitis C, Accident, USD, Trauma, Reagent, Risk, The, Aortic aneurysm, Blood, Gastrointestinal bleeding, Prevalence, Hospital, Conditional sentence, Syphilis, Medical device, Instrument

The global blood transfusion diagnostics market size is expected to reach USD 5.8 billion by 2027.

Key Points: 
  • The global blood transfusion diagnostics market size is expected to reach USD 5.8 billion by 2027.
  • The growing prevalence of chronic diseases coupled with increasing demand for disease screening is significantly driving the market growth.
  • Some of the chronic infectious diseases such as hepatitis B, hepatitis C, HIV, and syphilis create the need for accurate donor screening, further driving the market growth.
  • There is an increasing risk of Transfusion-transmitted Infections (TTIs) that has led to high demand for donor screening.